GFR Decline as an End Point for Clinical Trials in CKD: A Scientific Workshop Sponsored by the National Kidney Foundation and the US Food and Drug Administration
Tufts Medical Center · Johns Hopkins University · +5 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
587
total citations
- FWCI
- 19.83
- Percentile
- 100%
- References
- 44
Citations per year
Authors
9Topics & keywords
Topics
Keywords
- Medicine
- Kidney disease
- Renal function
- Creatinine
- Clinical trial
- Intensive care medicine
- Surrogate endpoint
- Food and drug administration
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.